158 related articles for article (PubMed ID: 34839983)
1. Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo.
Farag AGA; Badr EAE; El-Shafey AES; Elshaib ME
An Bras Dermatol; 2022; 97(1):28-36. PubMed ID: 34839983
[TBL] [Abstract][Full Text] [Related]
2. Fasting serum level of fatty-acid-binding protein 4 positively correlates with metabolic syndrome in patients with coronary artery disease.
Hsu BG; Chen YC; Lee RP; Lee CC; Lee CJ; Wang JH
Circ J; 2010 Feb; 74(2):327-31. PubMed ID: 20009357
[TBL] [Abstract][Full Text] [Related]
3. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
[TBL] [Abstract][Full Text] [Related]
4. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
5. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome].
Hu WH; Qiao J; Li R; Wang LN
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783
[TBL] [Abstract][Full Text] [Related]
6. Serum fatty acid binding protein 4, free fatty acids, and metabolic risk markers.
Karakas SE; Almario RU; Kim K
Metabolism; 2009 Jul; 58(7):1002-7. PubMed ID: 19394980
[TBL] [Abstract][Full Text] [Related]
7. FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants.
Ibarretxe D; Girona J; Plana N; Cabré A; Heras M; Ferré R; Merino J; Vallvé JC; Masana L
Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):875-880. PubMed ID: 26141940
[TBL] [Abstract][Full Text] [Related]
8. A Notorious Trio! Inflammation, Metabolic Syndrome and Vitiligo.
Mustafa AI; Hamed AM; Kadah AS; Fawzy EM; El Shimi OS
Indian Dermatol Online J; 2023; 14(4):493-499. PubMed ID: 37521222
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels.
Lamounier-Zepter V; Look C; Ehrhart-Bornstein M; Bornstein SR; Fischer S; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):129-34. PubMed ID: 23357154
[TBL] [Abstract][Full Text] [Related]
10. FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis.
Tan M; Korkmaz H; Aydın H; Kumbul Doğuç D
Turk J Med Sci; 2019 Oct; 49(5):1490-1497. PubMed ID: 31651119
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid binding protein 4 (FABP4) and metabolic-related parameters in systemic lupus erythematosus active and non-active episode.
Hamijoyo L; Putri M; Alita VR; Atik N; Syamsunarno MRA
Lupus; 2021 Jun; 30(7):1133-1139. PubMed ID: 33840283
[TBL] [Abstract][Full Text] [Related]
12. Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin.
Baran A; Kiluk P; Świderska M; Maciaszek M; Myśliwiec H; Flisiak I
Lipids; 2019 Aug; 54(8):445-452. PubMed ID: 31281982
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in vitiligo patients among a semi-urban Maharashtrian population: A case control study.
Sharma YK; Bansal P; Menon S; Prakash N
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S77-S80. PubMed ID: 28017282
[TBL] [Abstract][Full Text] [Related]
15. Increased Risk of Metabolic Syndrome in Patients with Vitiligo.
Ataş H; Gönül M
Balkan Med J; 2017 May; 34(3):219-225. PubMed ID: 28443562
[TBL] [Abstract][Full Text] [Related]
16. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults.
Rhee EJ; Lee WY; Park CY; Oh KW; Kim BJ; Sung KC; Kim BS
Eur J Endocrinol; 2009 Feb; 160(2):165-72. PubMed ID: 19001529
[TBL] [Abstract][Full Text] [Related]
17. The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.
Andrés Cerezo L; Kuklová M; Hulejová H; Vernerová Z; Pešáková V; Pecha O; Veigl D; Haluzík M; Pavelka K; Vencovský J; Senolt L
Cytokine; 2013 Oct; 64(1):441-7. PubMed ID: 23714112
[TBL] [Abstract][Full Text] [Related]
18. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Heras M; Masana L
J Lipid Res; 2008 Aug; 49(8):1746-51. PubMed ID: 18421072
[TBL] [Abstract][Full Text] [Related]
19. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
[TBL] [Abstract][Full Text] [Related]
20. Circadian clock gene expression and polymorphism in non-segmental vitiligo.
Farag AGA; Badr EAE; Ibrahim AF
Mol Biol Rep; 2024 Jan; 51(1):142. PubMed ID: 38236441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
